Healthline
November 9, 2025
Share on PinterestA common drug used as an emergency contraceptive may also help lower breast cancer risk. Tom Werner/Getty Images Researchers say that a drug used […]
November 8, 2025
Share on PinterestA new study found that waist-to-height ratio was closely linked to heart disease risk than BMI or waist circumference. Ableimages/Getty Images A new study […]
November 6, 2025
Share on PinterestShort-term fasting is unlikely to have a significant impact on mental sharpness, according to new research. Johner Images/Getty Images Researchers report that intermittent fasting […]
November 5, 2025
Share on PinterestA new study raises concerns over long-term melatonin use and cardiovascular risks. Viktoriya Skorikova/Getty Images Researchers say people with insomnia who use melatonin supplements […]
Medscape
July 8, 2025
Obesity often brings about, or exacerbates, depression and anxiety. Yet some of the most effective drugs for managing depression are also known to cause weight gain. […]
July 8, 2025
Despite dramatic treatment advances in recent years, the dermatology community has lacked a unified definition for what remission means in plaque psoriasis. Now, a multistage Delphi […]
July 8, 2025
Could a simple advisory or alert in the electronic medical record (EMR) be the key to more frequent diagnosis and effective treatment of high blood pressure […]
July 8, 2025
In young children, the long-term effects of SARS-CoV-2 infection may differ significantly from those in older children or adults. A recent study in JAMA Pediatrics systematically […]
FDA
November 7, 2025
Summary Company Announcement Date: November 06, 2025 FDA Publish Date: November 07, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Out-of-specification endotoxin results Company […]
November 6, 2025
On November 6, 2025, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) for adults with high-risk smoldering multiple myeloma (SMM). […]
November 6, 2025
Docket Number: FDA-2017-D-0040 Issued by: Guidance Issuing Office Office of the Commissioner, Office of the Chief Medical Officer, Office of Combination Products This guidance is intended […]
November 5, 2025
Product: Drugs Recipient: Glowface United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
